Figure 4.
The morphological changes during the establishment of A549/Docetaxel (200×) examined by light microscope. (A) The original morphology of A549. (B) The morphology of A549 with the treatment of docetaxel at the beginning. (C) The morphology of the A549/Docetaxel with a more obvious “mesenchymal” phenotype.